PATENT CLAIM ANALYSIS

Application Number: 16073580
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-02
Patent Classification: ["514", "731000"]

Abstract:
Disclosed herein is an aqueous pharmaceutical formulation comprising about 10 mg/mL of propofol, 175 mg/mL of sulfobutylether β-cyclodextrin, a citric buffer, wherein the composition has a pH of about 5.5. Also disclosed is a method of inducing and maintaining anesthesia or sedation in a patient by administering the aqueous pharmaceutical formulation.

Claim (Index 32):
A method of initiating monitored anesthesia care sedation in a patient in need thereof, the method comprising administering to said patient a pharmaceutical composition comprising about 10 mg/mL of propofol, 175 mg/mL of sulfobutylether \u03b2-cyclodextrin, a citric buffer, and water for injection, and wherein the propofol is administered to the patient at a rate of about 5 to about 12 mg/kg/h to induce effective sedation or anesthesia.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['09820371', '10766631', '13704145', '14668683', '10629308']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8228976520952606
- 35 USC 102 Novelty (BERT): 0.5120953359688399
- Combined Prediction Score: 0.7918174204826185
- Mean Citation Score: 294.763554
- Max Citation Score: 309.28638
- Similarity Product: 228.5104156661868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test